US 8143279
Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
granted A61PA61P1/00A61P1/04
Quick answer
US patent 8143279 (Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists) held by Theravance, Inc. expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P1/10, A61P1/14